Hepatic steatosis has been reported as one of the characteristics which discriminates hepatitis C from other forms of hepatitis, besides lymphoid follicles and bile duct damage. However, it is unclear whether or not the presence of hepatitis C virus (HCV) itself is associated with the development of
Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis
โ Scribed by Gloria Taliani; Franca Duca; Rosina Lecce; Donatella Livoli; Caterina Pasquazzi; Carlo De Bac; Andrea Fabbri; Giampaolo P. Bianchi; Guilio Marchesini
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 283 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatic steatosis is common in chronic hepatitis C and has been linked to concurrent obesity, insulin resistance, diabetes, disease severity, and poor response to therapy. Racial differences in rates of obesity and diabetes may contribute to racial differences in hepatic steatosis and treatment resp
## Abstract DOI 10.1002/cncr.11440
We have read with interest the article of Dr. Fartoux and colleagues, 1 who assessed the factors involved in the progression of fibrosis in 135 mild chronic hepatitis C (CHC) patients who underwent paired liver biopsies after a median of 61 months. Steatosis was the only determinant of fibrosis prog
## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of